D-Lysine

• Description :

  D-Lysine is a useful raw material employed as an analog of lutenizing-hormone-releasing hormone and as a agent carrier in the form of polylysine. D-Lysine decreases renal uptake of radioactivity during scintigraphy and PRRT with low toxicity. D-Lysine not interferes with the natural amino acid metabolic balance[1][2].

• CAS Number :

  [923-27-3]

• UNSPSC :

  12352209

• Hazard Statement :

  H302, H315, H319, H335

• Target :

  Endogenous Metabolite

• Type :

  Peptides

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  Metabolism-protein/nucleotide metabolism

• Field of Research :

  Others

• Assay Protocol :

  https://www.medchemexpress.com/d-lysine.html

• Purity :

  98.29

• Solubility :

  H2O : 100 mg/mL (ultrasonic)

• Smiles :

  N[C@H](CCCCN)C(O)=O

• Molecular Formula :

  C6H14N2O2

• Molecular Weight :

  146.19

• Precautions :

  H302, H315, H319, H335

• References & Citations :

  [1]Bernard BF, et al. D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake. J Nucl Med. 1997 Dec;38 (12) :1929-33.|[2]Takahashi E, et al. D-lysine production from L-lysine by successive chemical racemization and microbial asymmetric degradation. Appl Microbiol Biotechnol. 1997 Apr;47 (4) :347-51.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -20°C (Powder, protect from light)

• Scientific Category :

  Peptides

• Clinical Information :

  No Development Reported

• Isoform :

  Human Endogenous Metabolite